Median survival times ‐ not reported · patients with oesophageal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to progression · patients with oesophageal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life ‐ number experiencing improvement · patients with oesophageal cancer
Active cancer therapy combined with TCM may leads to higher quality of life ‐ number experiencing improvement compared with active cancer therapy (low certainty).
1 finding from 1 review
Quality of life ‐ number experiencing deterioration · patients with oesophageal cancer
Active cancer therapy combined with TCM may leads to lower quality of life ‐ number experiencing deterioration compared with active cancer therapy (low certainty).
1 finding from 1 review
Quality of life ‐ Karnofsky performance status Karnofsky status judged by clinicians. Scale: 0 to 100 · patients with oesophageal cancer
1 finding from 1 review
Complete or partial remission · patients with oesophageal cancer
Active cancer therapy combined with TCM probably leads to higher short‐term therapeutic effects ‐ improvement (complete response +… compared with active cancer therapy (moderate certainty).
1 finding from 1 review
Short‐term therapeutic effects ‐ progressive disease · patients with oesophageal cancer
Active cancer therapy combined with TCM showed no clear difference in short‐term therapeutic effects ‐ progressive disease compared with active cancer therapy (low certainty).
1 finding from 1 review
TCM symptoms ‐ total effectiveness · patients with oesophageal cancer
It is very uncertain whether active cancer therapy combined with TCM changes TCM symptoms ‐ total effectiveness compared with active cancer therapy (very low certainty).
1 finding from 1 review
Outcomesa · women with menopausal symptoms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vasomotor symptoms (vasomotor) · women with menopausal symptoms
1 finding from 1 review
Adverse effects · women with menopausal symptoms
It is very uncertain whether CHM changes adverse Effects compared with HT (very low certainty).
1 finding from 1 review
Effectiveness · women with recurrent UTI
It is very uncertain whether CHM changes effectiveness compared with antibiotics (very low certainty).
1 finding from 1 review
Recurrence · women with recurrent UTI
It is very uncertain whether CHM changes recurrence compared with antibiotics (very low certainty).
1 finding from 1 review
Effectiveness · women with recurrent UTI
It is very uncertain whether CHM plus antibiotics changes effectiveness compared with antibiotics (very low certainty).
1 finding from 1 review
Recurrence · women with recurrent UTI
It is very uncertain whether CHM plus antibiotics changes recurrence compared with antibiotics (very low certainty).
1 finding from 1 review
Effectiveness · women with recurrent UTI
It is very uncertain whether CHM changes effectiveness compared with CHM (very low certainty).
1 finding from 1 review
Recurrence · women with recurrent UTI
It is very uncertain whether CHM changes recurrence compared with CHM (very low certainty).
1 finding from 1 review
Quality of life · women with recurrent UTI
1 finding from 1 review
All‐cause mortality · patients with heart failure
1 finding from 1 review
Hospitalization/ rehospitalization · patients with heart failure
1 finding from 1 review